Short answer · Medically reviewed summary · Last updated: 2026-04-06
The primary medical term for this condition is Marfan syndrome, though it is occasionally referred to as Marfan's syndrome or by its historical designation, dystrophia mesodermalis congenita. Common Synonyms and Historical Nomenclature While Marfan syndrome is the universally accepted clinical term, you may encounter several variations in older medical records or international literature. Historically, the condition was described as dystrophia mesodermalis congenita, reflecting early theories about its origin in connective tissue.
The primary medical term for this condition is Marfan syndrome, though it is occasionally referred to as Marfan's syndrome or by its historical designation, dystrophia mesodermalis congenita.
While Marfan syndrome is the universally accepted clinical term, you may encounter several variations in older medical records or international literature. Historically, the condition was described as dystrophia mesodermalis congenita, reflecting early theories about its origin in connective tissue. You may also see it abbreviated as MFS in clinical notes and research papers. Because the condition affects the skeletal, cardiovascular, and ocular systems simultaneously, it has occasionally been described in older texts as arachnodactyly, though this term refers only to the long, slender fingers often associated with the syndrome rather than the condition as a whole.
Medical professionals and international health organizations standardize the name to ensure consistent diagnosis and research. Under the International Classification of Diseases (ICD-10/11), the condition is officially categorized as Marfan syndrome. Similarly, the Online Mendelian Inheritance in Man (OMIM) database lists it under entry #154700, and it is recognized by Orphanet as ORPHA:558. These authoritative bodies prioritize the name Marfan syndrome to honor Antoine Marfan, who first described the clinical features in 1896.
The variation in terminology is largely due to the evolution of medical diagnostics over the last century. As our understanding of the FBN1 gene mutation progressed, the medical community moved away from descriptive, symptom-based names (like arachnodactyly) toward a unified eponym. Today, Marfan syndrome is the preferred term used by geneticists, cardiologists, and ophthalmologists worldwide. Using this official terminology is the most effective way to ensure your medical records are accurately interpreted by specialists across different healthcare systems.
Medical Disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.